Mr. Speaker, we have not yet determined the best path forward. We have asked an expert panel to make recommendations about how to best help Canadians who are struggling and making impossible choices, like the member opposite so eloquently described.
That is why we are actually not only just moving forward with that panel but we are moving forward with concrete measures, like joining the pan-Canadian pharmaceutical alliance, which means Canadians save over $1 billion annually. We have put forward major reforms to patented medicines regulations. We are continuing to do the work to make sure that Canadians get—